Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Glaucoma

In brief

The purpose of this study is to evaluate the safety and effectiveness in lowering intraocular pressure (IOP) utilizing an experimental lotion containing 0.005% Latanoprost that is applied to the outside of one eyelid.

Key facts

Study ID
NCT01426464
Run by
Nanduri, Padma, M.D., FACS
People needed
22
Starts
2011-09-01
Expected to finish
2011-12-01
Last updated by the study team
2011-08-31

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.